Elevance Health Inc. (NYSE:ELV)

The financial trajectory from 2021 to 2025 indicates a transition from positive economic value creation to sustained value destruction. While the company has consistently expanded its capital base, the operational returns have failed to keep pace with the cost of that capital, resulting in a negative economic profit trend starting in 2023.

Net Operating Profit After Taxes (NOPAT)

NOPAT exhibits a volatile and generally downward trend, decreasing from 7,193 million USD in 2021 to 6,650 million USD by 2025. A temporary recovery occurred in 2024, where profit rose to 7,015 million USD, but this gain was not sustained into the following year. This lack of consistent growth in operational earnings undermines the company's ability to generate economic surplus.

Invested Capital

A consistent upward trend is observed in invested capital, which grew steadily from 63,876 million USD in 2021 to 80,815 million USD in 2025. The continuous increase in the capital base, without a proportional increase in NOPAT, suggests a diminishing return on invested capital (ROIC).

Cost of Capital

The cost of capital peaked at 9.92% in 2023 before trending downward to 9.04% by 2025. Despite this reduction in the required rate of return during the final two years, the decline was insufficient to offset the combined impact of the expanding capital base and stagnant operational profits.

Economic Profit

Economic profit shifted from a positive 1,049 million USD in 2021 to a deficit of 653 million USD in 2025. The company crossed into negative territory in 2023, signaling that the returns generated from operations were no longer sufficient to cover the cost of the capital employed. Although there was a marginal improvement in 2024, the overall trend confirms a deepening state of value destruction.

The divergence between the steady increase in invested capital and the fluctuating NOPAT is the primary driver of the negative economic profit. The company is investing more capital into the business, but these investments are not yielding operational gains high enough to exceed the cost of funding.

Analysis of the presented financial information reveals trends in both shareholders’ net income and net operating profit after taxes (NOPAT) over a five-year period. While shareholders’ net income demonstrates a consistent, albeit gradual, decline, NOPAT exhibits more fluctuation.

Shareholders’ Net Income

Shareholders’ net income decreased steadily from US$6,104 million in 2021 to US$5,662 million in 2025. This represents a cumulative decrease of approximately 7.9% over the five-year period. The annual declines were relatively consistent, ranging from approximately 0.7% to 2.2% year-over-year.

Net Operating Profit After Taxes (NOPAT)

NOPAT experienced a more varied trajectory. It decreased from US$7,193 million in 2021 to US$6,415 million in 2023, representing a decline of approximately 10.8%. However, NOPAT then increased significantly to US$7,015 million in 2024, before decreasing again to US$6,650 million in 2025. The increase in 2024 suggests a potential improvement in operational efficiency or a favorable shift in the business environment during that year. The subsequent decrease in 2025 partially offsets the gains made in 2024.

The divergence between the trends in shareholders’ net income and NOPAT is noteworthy. While net income consistently declined, NOPAT demonstrated volatility, including a substantial increase in 2024. This suggests that factors beyond core operational profitability, such as changes in financing costs, non-operating income/expenses, or tax rates, may be influencing shareholders’ net income. Further investigation into these areas would be beneficial to understand the drivers behind the observed trends.

Relationship between NOPAT and Net Income

In 2021, NOPAT exceeded shareholders’ net income by US$1,089 million. This difference narrowed in 2022 to US$816 million, and further to US$502 million in 2023. In 2024, NOPAT exceeded net income by US$1,035 million, and in 2025, the difference was US$988 million. The fluctuating difference between these two metrics indicates changes in the proportion of earnings attributable to shareholders versus operational performance.

Overall, the financial information indicates a weakening trend in shareholders’ net income coupled with fluctuating operational profitability as measured by NOPAT. The increase in NOPAT in 2024 is a positive sign, but the subsequent decline in 2025 warrants further scrutiny.

The reported income tax expense and cash operating taxes exhibit distinct patterns over the five-year period. While income tax expense generally remains relatively stable, cash operating taxes demonstrate more significant fluctuations.

Income Tax Expense

Income tax expense decreased from US$1,830 million in 2021 to US$1,750 million in 2022, followed by a further slight decrease to US$1,724 million in 2023. A subsequent increase is observed in 2024, reaching US$1,933 million, before a substantial decline to US$1,049 million in 2025. This suggests potential impacts from changes in tax regulations, accounting adjustments, or profitability levels.

Cash Operating Taxes

Cash operating taxes increased from US$1,823 million in 2021 to US$1,931 million in 2022. A notable increase occurred in 2023, with cash operating taxes reaching US$2,637 million, followed by a slight decrease to US$2,550 million in 2024. A significant decrease is then observed in 2025, with cash operating taxes falling to US$1,627 million. This pattern indicates a greater sensitivity to underlying business operations and potentially timing differences between reported income tax expense and actual cash outflows for taxes.

The divergence between income tax expense and cash operating taxes is particularly pronounced in 2023, 2024, and 2025. This difference could be attributed to factors such as deferred tax assets or liabilities, changes in tax credits utilized, or variations in the timing of tax payments relative to reported income. The substantial decrease in both income tax expense and cash operating taxes in 2025 warrants further investigation to understand the underlying drivers.

Relationship between Metrics

In 2021 and 2022, cash operating taxes closely mirrored income tax expense. However, from 2023 onwards, a growing disparity emerges. This suggests that non-cash tax items are becoming increasingly influential in the overall tax profile. The largest difference is seen in 2025, where cash operating taxes are significantly lower than income tax expense.

The invested capital of the organization demonstrates a consistent upward trend over the five-year period. Total reported debt & leases and shareholders’ equity both contribute to this increase, with invested capital representing the sum of these two components.

Total Reported Debt & Leases

Total reported debt & leases increased from US$24,028 million in 2021 to US$32,706 million in 2025. The rate of increase accelerated between 2022 and 2024, growing by US$6,074 million, significantly larger than the increase observed between 2021 and 2022 (US$1,018 million). The increase from 2024 to 2025 was more moderate, at US$663 million.

Shareholders’ Equity

Shareholders’ equity also exhibited growth throughout the period, rising from US$36,060 million in 2021 to US$43,882 million in 2025. The growth was relatively consistent year-over-year, with increases ranging from US$247 million to US$2,509 million annually. The largest single-year increase occurred between 2022 and 2023.

Invested Capital

As a result of the increases in both debt & leases and shareholders’ equity, invested capital grew from US$63,876 million in 2021 to US$80,815 million in 2025. The growth rate of invested capital mirrors the trends in its components, with a notable acceleration between 2023 and 2024, increasing by US$8,572 million. The increase from 2024 to 2025 was US$2,564 million, representing a deceleration in growth.

The consistent growth in invested capital suggests ongoing investment in the organization’s operations and expansion. The increasing reliance on debt financing, particularly between 2022 and 2024, warrants further investigation to assess the associated financial risk and the effectiveness of capital allocation.

The financial performance regarding economic value creation demonstrates a marked deterioration between 2021 and 2025. While the organization expanded its capital base, this growth did not translate into commensurate economic gains, resulting in a shift from value creation to value destruction.

Economic Profit Trends

A significant contraction in economic profit is evident, falling from a peak of US$ 1,049 million in 2021 to a deficit of US$ 653 million by 2025. The transition into negative territory occurred in 2023, indicating that operating profits became insufficient to cover the cost of invested capital. Although a marginal improvement was noted in 2024, the trend resumed a downward trajectory in 2025, reaching the lowest point in the observed period.

Invested Capital Growth

Invested capital exhibited a consistent and uninterrupted upward trajectory, increasing from US$ 63,876 million in 2021 to US$ 80,815 million in 2025. This steady expansion of the capital base occurred concurrently with the decline in economic profit, suggesting that the additional capital deployed failed to generate returns that exceeded the cost of capital.

Economic Spread Ratio Analysis

The economic spread ratio mirrors the decline in economic profit, dropping from 1.64% in 2021 to -0.81% in 2025. The shift to a negative ratio in 2023 represents a critical inflection point where the return on invested capital fell below the cost of capital. The persistent negative values through 2024 and 2025 confirm a sustained inability to create economic value, with the spread narrowing and then expanding further into negative territory.

An analysis of the financial performance between 2021 and 2025 reveals a significant divergence between top-line growth and economic value creation. While operating revenue exhibited consistent growth throughout the period, economic profit shifted from positive territory to a sustained negative trend, indicating that the company's returns have failed to exceed its cost of capital in recent years.

Economic Profit Trends

A sharp decline in economic profit is observed, starting from a peak of US$ 1,049 million in 2021 and falling to US$ 219 million in 2022. The trend transitioned into negative territory in 2023 with a loss of US$ 495 million. Despite a brief moderate recovery in 2024 to negative US$ 302 million, the value deteriorated further by 2025, reaching negative US$ 653 million.

Operating Revenue Growth

Operating revenue demonstrated a steady upward trajectory over the five-year period. Revenue increased from US$ 136,943 million in 2021 to US$ 197,584 million by 2025. This consistent growth indicates an expansion in scale and market activity, though this expansion did not translate into increased economic profit.

Economic Profit Margin Analysis

The economic profit margin reflects the eroding efficiency of value creation. The margin compressed from 0.77% in 2021 to 0.14% in 2022, eventually turning negative in 2023 at -0.29%. Although 2024 saw a slight improvement to -0.17%, the margin fell again to -0.33% in 2025. This trajectory suggests that the cost of the capital employed has grown at a rate that outweighs the gains from increased operating revenue.